STAT June 19, 2019
Casey Ross

BOSTON — Artificial intelligence is often hailed as a great catalyst of medical innovation, a way to find cures to diseases that have confounded doctors and make health care more efficient, personalized, and accessible.

But what if it turns out to be poison?

Jonathan Zittrain, a Harvard Law School professor, posed that question during a conference in Boston Tuesday that examined the use of AI to accelerate the delivery of precision medicine to the masses. He used an alarming metaphor to explain his concerns:

“I think of machine learning kind of as asbestos,” he said. “It turns out that it’s all over the place, even though at no point did you explicitly install it, and it has possibly some latent...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Conferences / Podcast, Technology, Trends
Coventry Uni uses AI-generated avatars to train medical students
When your company's newest board member is an AI
205: Live from ViVE 2024: Four leaders on how technology is redefining clinical work
The Future of Human Health May Require Unlocking Access to Our Health Data
AI Ushers in HPC Revival Says TACC’s Dan Stanzione

Share This Article